World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
23812
World Ranking
1184
National Ranking
625

Mitzi Nagarkatti publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mitzi Nagarkatti sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 534 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mitzi Nagarkatti D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mitzi Nagarkatti sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2020 - Fellow, National Academy of Inventors
  • 2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Mitzi Nagarkatti is affiliated with the University of South Carolina in the United States. Their research spans multiple fields, primarily focusing on immunology, microbiology, medicine, and molecular biology.

Their main fields of study include:

  • Immunology and Microbiology
  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, Nagarkatti's work further delves into subfields such as:

  • Immunology
  • Molecular Biology
  • Pharmacology
  • Epidemiology
  • Cancer Research

Research topics addressed by Nagarkatti include:

  • Immune Cell Function and Interaction
  • Gut microbiota and health
  • Immune cells in cancer
  • Immune Response and Inflammation
  • IL-33, ST2, and ILC Pathways
  • Tryptophan and brain disorders
  • Cannabis and Cannabinoid Research

Frequent publication venues for Nagarkatti's work are:

  • The Journal of Immunology
  • Frontiers in Immunology
  • International Journal of Molecular Sciences
  • The FASEB Journal
  • Frontiers in Pharmacology

Some of the recent papers authored with various collaborators are:

  • "Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22-dependent manner," 2020, JCI Insight
  • "Alterations in the Gut Microbiome and Suppression of Histone Deacetylases by Resveratrol Are Associated with Attenuation of Colonic Inflammation and Protection Against Colorectal Cancer," 2020, Journal of Clinical Medicine
  • "Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction through liver-brain axis in murine model of nonalcoholic steatohepatitis," 2020, Journal of Neuroinflammation
  • "The Ability of Resveratrol to Attenuate Ovalbumin-Mediated Allergic Asthma Is Associated With Changes in Microbiota Involving the Gut-Lung Axis, Enhanced Barrier Function and Decreased Inflammation in the Lungs," 2022, Frontiers in Immunology
  • "Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases," 2021, International Journal of Molecular Sciences

Frequent coauthors include:

  • Prakash Nagarkatti
  • Kiesha Wilson
  • Philip Brandon Busbee
  • Narendra P. Singh
  • Kathryn Miranda

Mitzi Nagarkatti has received recognition including:

  • Fellow, National Academy of Inventors (2020)
  • Fellow of the American Association for the Advancement of Science (AAAS) (2012)

Best Publications

  • Cannabinoids as novel anti-inflammatory drugs

    Prakash Nagarkatti;Rupal Pandey;Sadiye Amcaoglu Rieder;Venkatesh L Hegde

  • Role of cytokines as a double-edged sword in sepsis.

    Hina Chaudhry;Juhua Zhou;Juhua Zhou;Yin Zhong;Mir Mustafa Ali

  • Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

    Robert J McKallip;Catherine Lombard;Michael T Fisher;Billy R Martin

  • Chemokine and cytokine levels in inflammatory bowel disease patients

    Udai P. Singh;Narendra P. Singh;E. Angela Murphy;Robert L. Price

  • Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

    Sadiye Amcaoglu Rieder;Ashok Chauhan;Ugra Singh;Mitzi Nagarkatti

  • Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis.

    Narendra P. Singh;Udai P. Singh;Balwan Singh;Robert L. Price

  • Δ-9-Tetrahydrocannabinol Enhances Breast Cancer Growth and Metastasis by Suppression of the Antitumor Immune Response

    Robert J. McKallip;Mitzi Nagarkatti;Prakash S. Nagarkatti

  • Endocannabinoids and immune regulation.

    Rupal Pandey;Khalida Mousawy;Mitzi Nagarkatti;Prakash Nagarkatti

  • Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner

    Rajeev Mehla;Shalmali Bivalkar-Mehla;Ruonan Zhang;Indhira Handy

  • Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression.

    Robert J. McKallip;Wentao Jia;Jerome Schlomer;James W. Warren

  • Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis

    Xiangli Cui;Yu Jin;Anne B. Hofseth;Edsel Pena

  • Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis

    Xinting Ma;Juhua Zhou;Yin Zhong;Linlin Jiang

  • Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor.

    Narendra P. Singh;Venkatesh L. Hegde;Lorne J. Hofseth;Mitzi Nagarkatti

  • Activation through Cannabinoid Receptors 1 and 2 on Dendritic Cells Triggers NF-κB-Dependent Apoptosis: Novel Role for Endogenous and Exogenous Cannabinoids in Immunoregulation

    Yoonkyung Do;Robert J. McKallip;Mitzi Nagarkatti;Prakash S. Nagarkatti

  • Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.

    Philip B Busbee;Michael Rouse;Mitzi Nagarkatti;Prakash S Nagarkatti

  • A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.

    Linmao Lyu;Hui Wang;Bin Li;Qingyun Qin

  • Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.

    Robert J. McKallip;Catherine Lombard;Billy R. Martin;Mitzi Nagarkatti

  • Resveratrol (Trans-3,5,4′-trihydroxystilbene) Induces Silent Mating Type Information Regulation-1 and Down-Regulates Nuclear Transcription Factor-κB Activation to Abrogate Dextran Sulfate Sodium-Induced Colitis

    Udai P. Singh;Narendra P. Singh;Balwan Singh;Lorne J. Hofseth

  • Dysregulation in microRNA expression is associated with alterations in immune functions in combat veterans with post-traumatic stress disorder.

    Juhua Zhou;Prakash Nagarkatti;Yin Zhong;Jay P. Ginsberg

  • Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice

    Kandy T Velázquez;Reilly T Enos;Jackie E Bader;Alexander T Sougiannis

  • Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo.

    Arati B. Kamath;Huimin Xu;Prakash S. Nagarkatti;Mitzi Nagarkatti

Frequent Co-Authors

Prakash S. Nagarkatti
Prakash S. Nagarkatti University of South Carolina
Chuanbing Tang
Chuanbing Tang University of South Carolina
Dennis D. Taub
Dennis D. Taub George Washington University
Alan W. Decho
Alan W. Decho University of South Carolina
Anna Mae Diehl
Anna Mae Diehl Duke University
Bryan W. Brooks
Bryan W. Brooks Baylor University
James A. Carson
James A. Carson University of Tennessee Health Science Center
Swapan K. Ray
Swapan K. Ray University of South Carolina
Xuejun Wang
Xuejun Wang University of South Dakota
Bruce A. Lessey
Bruce A. Lessey Wake Forest Baptist Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, expanding your knowledge through nursing programs can open diverse career pathways. Many professionals start with foundational nursing degrees. For non-nurses looking to break into the healthcare field quickly, online absn programs for non nurses offer an accelerated route to becoming a registered nurse.

If you already hold a nursing degree, enhancing your qualifications through an accelerated fnp program can fast-track your transition into specialized family nurse practitioner roles, which often intersect with immunology-related care.

For nurses aiming to specialize further, obtaining an fnp to acute care certification is a critical step. This certification allows practitioners to handle acute patient scenarios, including immunological conditions requiring advanced care.

Additionally, when choosing a program, consider the ease of admission to ensure a smooth educational journey. Resources highlighting the easiest absn to get into can help prospective students find accessible nursing programs that align with their goals.

Best Scientists Citing Mitzi Nagarkatti

Trending Scientists

Recently Published Articles